In the last ten years pertussis has re-emerged in many regions including the European Union (EU) and European Economic Area (EEA), despite high and stable vaccine coverage with the primary series of acellular pertussis vaccine.
Pertussis can lead to severe disease in infants. PERTINENT aims at setting up a European hospital network to address key questions on the burden of pertussis in infants less than one year of age, as well as the vaccine effectiveness and impact of different pertussis vaccination strategies in the EU/EEA.
The project “Setting up a sentinel system to assess the burden of whooping cough in EU/EEA” is funded by ECDC, coordinated by EpiConcept and involves seven study sites and four expert partners from 10 EU/EEA member states.
For more information: